Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Targeted Genetics initiates phase II trials for proprietary gene therapy compound

Oct. 8, 1998

Onconase and proteasome inhibitors have synergistic antitumor activity, even in resistant tumors

Oct. 8, 1998

ADIR presents two new series of ellipticine derivatives with improved profiles

Oct. 7, 1998

Antitumor agents with high potency and selectivity under evaluation at Shionogi

Oct. 6, 1998

Inex to focus internal R&D program on three cancer drug product candidates

Oct. 6, 1998

FDA approves anthracycline with orphan drug status for carcinoma in situ of the bladder

Oct. 5, 1998

Janssen terminates Avicidin agreement with NeoRx

Oct. 2, 1998

Onyx expands ONYX-015 clinical trials in pancreatic cancer

Oct. 2, 1998

Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika

Oct. 1, 1998

Guilford, RPR amend Gliadel marketing and distribution agreement

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...